What We Say is What We Do


As a full service, international CRO with three decades of experience directing global Phase I – IV clinical development programs leading to more than 240 product approvals, Synteract has proven it is uniquely positioned to help clients successfully navigate the complex drug development process. We understand that mindful clinical development, where efficiency is maximized, is critical to the long-term success of our biopharmaceutical clients.

Our Approach Ensures Clear Focus

Our deep “Shared Work-Shared Vision” culture means we collaborate with every client to tailor an approach to fit your specific project needs, offering guidance across the spectrum of Phase I – IV clinical studies. Our deep commitment to sponsors means we understand that you must get to decision points as quickly as possible while maintaining high quality and consistent standards internationally.

We focus together on your goals from the outset, and strategically adapt services for each project, to ensure every aspect of a project is planned for and delivered as promised at a competitive price. We leverage deep clinical and therapeutic expertise, appropriate technology, and optimized process execution to drive solution-oriented efficiencies on a global scale.

We know that one size does not fit all when it comes to clinical development. Given the high percentage of referrals and repeat business we have had, Synteract has proven success in our tailored approach, especially among emerging to mid-sized pharma, biotech, and device companies, a unique industry segment we have served since our founding.

Relationships and Timeliness Matter

At Synteract, we foster enduring relationships with our clients and partners. Responsive customer service isn’t just a phrase; it’s a promised standard that includes ongoing support from a specialized team dedicated to exceeding your expectations and accelerating your clinical development timelines.


Contact Synteract

Tell us how to stay in touch with you: